• Alexander Fleming, USA | Congress Co-Chair

    Alexander Fleming, USA | Congress Co-Chair

    Dr. Alexander Fleming received his M.D. and internal medicine training from Emory, fellowship training in endocrinology at Vanderbilt and metabolism at National Institutes of Health, where he was a senior fellow. 
    Read More..
  • Lawrence Steinman, USA I Congress Co-Chair

    Lawrence Steinman, USA I Congress Co-Chair

    Dr. Lawrence Steinman is Professor of Neurology, Neurological Sciences and Pediatrics at Stanford University and Chair of the Stanford Program in Immunology from 2001 to 2011. His research focuses on what provokes relapses and remissions in multiple sclerosis (MS) and in neuromyelitis optica (NMO) and the quest for antigen specific therapy. He is developing a small molecule therapeutic in trials for Huntington’s Disease.
  • Julia Manning, UK I Congress Co-Chair

    Julia Manning, UK I Congress Co-Chair

    Julia Manning is a social pioneer, writer, campaigner and commentator. Julia studied visual science at City University, became a member of the College of Optometrists in 1991 and specialised in diabetes.
  • Steven Austad, USA

    Steven Austad, USA

    Steven N. Austad is a distinguished professor and department chair in the Department of Biology at the University of Alabama at Birmingham.
  • Nir Barzilai, USA

    Nir Barzilai, USA

    Dr. Barzilai is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Glenn Center for the Biology of Human Aging and of the Nathan Shock Center of excellence in biology of aging.
  • Sir John Bell, UK

    Sir John Bell, UK

    Professor Sir John Bell GBE, FRS is Regius Professor of Medicine at Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research.  
  • Joseph C. Cook, Jr., USA

    Joseph C. Cook, Jr., USA

    Mr. Cook is a principal and co-founder of Mountain Group Capital, Nashville, TN.  Mr. Cook serves as Executive Chairman of the Board and President of NuSirt Biopharma and a board member of Castle Biosciences, Clinical Products and Corcept Therapeutics Inc. (NASDAQ: CORT).
  • Lars Fugger, UK

    Lars Fugger, UK

    Lars Fugger, MD, Ph.D., is a consultant clinical immunologist at the John Radcliffe Hospital at Oxford University Hospitals and professor of Neuroimmunology at the University of Oxford.

  • Jenny Gunton, Australia

    Jenny Gunton, Australia

    Professor Jenny Gunton is the Director of the Centre for Diabetes and Obesity Research at the Westmead Institute for Medical Research and is Chair of Medicine at Westmead Hospital, University of Sydney.  

  • Brian E. Harvey, USA

    Brian E. Harvey, USA

    Brian E. Harvey, MD, PhD is a physician and biochemist with academic research, clinical practice, U.S. FDA regulatory, bio-pharmaceutical industry and non-profit experience.  
  • Philip Home, UK

    Philip Home, UK

    Philip Home trained in medicine at Oxford University and Guy's Hospital, coming under the influence of Harry Keen, and thus gravitating into diabetes research. Continuing this research career in Newcastle upon Tyne, initially under the guidance of George Alberti, he has published over 390 papers, books and reviews on aspects of diabetes, from basic studies on metabolism to RCTs of new therapies, and aspects of the organization and delivery of diabetes health-care.
  • Joshua Hordern, UK

    Joshua Hordern, UK

    Joshua Hordern is Associate Professor of Christian Ethics in the Faculty of Theology and Religion at the University of Oxford and a Fellow of Harris Manchester College.
  • Stephen Kritchevsky, USA

    Stephen Kritchevsky, USA

    Stephen Kritchevsky is an epidemiologist specializing in nutrition, chronic disease and physical function in older adults.
  • Gillian Leng, UK

    Gillian Leng, UK

    Gillian Leng is the Deputy Chief Executive at NICE, the National Institute for Health and Care Excellence, and a visiting professor at King’s College London.

  • Teresa Niccoli, UK

    Teresa Niccoli, UK

    Dr Teresa Niccoli graduated with a first class degree in Natural Sciences from the University of Cambridge and completed her PhD studies under Nobel Prize winner Paul Nurse’s supervision at Cancer Research UK, studying cells polarity.
  • Tomas Olsson, Sweden

    Tomas Olsson, Sweden

    Prof. Tomas Olsson received his MD from University of Linköping, Sweden in 1977 and went on to complete his PhD in Medical Sciences in 1980. He obtained Specialist exam in Clinical Neurology in 1984 He was appointed as Professor of Molecular Medicine 1995, and  holds the post of Professor in Neurology at Karolinska Institutet, Sweden since 2008. 
  • Itamar Raz, Israel

    Itamar Raz, Israel

    Prof. Raz holds an MD from Hadassah Medical School at the Hebrew University of Jerusalem where he is a professor of Internal Medicine and the Director Emeritus of the Diabetes Unit at Hadassah University Hospital. 

  • Lucy Rose, USA

    Lucy Rose, USA

    From 1995-97, Ms. Rose served as the Director of the Office of Training and Communications for the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration. There she designed and implemented programs to improve external communications with the pharmaceutical industry, health care professionals, and consumers. 
  • Thomas Seoh, USA

    Thomas Seoh, USA

    Thomas Seoh is CEO of Kinexum, a strategic advisory firm with deep expertise in regulatory, clinical and other translational matters in the development of life science products.  He as previously held senior leadership positions in public and private, pharmaceutical, biotech and medical device companies for over 25 years.  
  • Randy Strong, USA

    Randy Strong, USA

    Dr. Strong is the holder of the Dielmann Distinguished Chair in Aging and is the Associate Director for Translational Research of the Barshop Institute for Longevity and Aging Studies. 
  • Barry Straube, USA

    Barry Straube, USA

    Barry M. Straube, M.D., is a national healthcare policy, quality, clinical/academic expert serving as a consultant, healthcare governance board member, and scientific advisory/payment advisory board for diverse healthcare organizations internationally. 
  • Stephanie Tilenius, USA

    Stephanie Tilenius, USA

    Stephanie Tilenius is the Founder and CEO of Vida Health, a next-generation mobile therapeutic and health coaching platform for chronic physical and mental health conditions deployed at Fortune 500 companies, large national payers and providers. Prior to starting Vida, Tilenius was with Kleiner Perkins Canfield & Byers, where she worked primarily with late-stage KPCB portfolio companies, with an emphasis on companies in the Digital Growth Fund.
  • Ashok Venkitaraman, UK

    Ashok Venkitaraman, UK

    Ashok is the Ursula Zoellner Professor of Cancer Research at the University of Cambridge, and the Director of the Medical Research Council (MRC) Cancer Unit. He trained in medicine at the Christian Medical College, Vellore, India, before completing his PhD at University College London. 

  • Eric Verdin, USA

    Eric Verdin, USA

    Eric Verdin is the President and Chief Executive Officer of the Buck Institute for Research on Aging. A native of Belgium, Dr. Verdin received his Doctorate of Medicine (MD) from the University of Liege and additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research.